Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Terminated 1

Sponsor Class

OTHER 9 INDUSTRY 4 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Inoperable œsophageal Cancer 1

Interventions

Radiotherapy 41 Cisplatin 36 Fluorouracil 17 Paclitaxel 15 Docetaxel 14 Cyclophosphamide 14 Carboplatin 14 Filgrastim 13 Doxorubicin 13 Gemcitabine 11 Etoposide 11 Capecitabine 10 Surgical Procedures, Operative 9 Methotrexate 9 Leucovorin 9 Chemotherapy, Adjuvant 9 Vincristine 8 Peripheral Blood Stem Cell Transplantation 8 Oxaliplatin 8 Dexamethasone 7 Bevacizumab 7 Topotecan 6 Radiotherapy, Conformal 6 Prednisone 6 Fenretinide 6 Cetuximab 6 Neoadjuvant Therapy 5 Mitomycin 5 Irinotecan 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NETWORK × Chemoradiotherapy × Clear all

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡